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Abstract
Background: Recent years have seen a growing research and policy interest in prevention in many developed
countries. However, the actual efforts and resources devoted to prevention appear to have lagged well behind the
lip service paid to the topic.
Discussion: We review the evidence on the considerable existing scope for health gains from prevention as well
as for greater prevention policy efforts in Germany. We also discuss the barriers to “more and better” prevention
and provide modest suggestions about how some of the obstacles could be overcome.
Summary: In Germany, there are substantial health gains to be reaped from the implementation of evidence-
based, cost-effective preventive interventions and policies. Barriers to more prevention include social, historical,
political, legal and economic factors. While there is sufficient evidence to scale up prevention efforts in some
public health domains in Germany, in general there is a comparative shortage of research on non-clinical
preventive interventions. Some of the existing barriers in Germany are at least in principle amenable to change,
provided sufficient political will exists. More research on prevention by itself is no panacea, but could help facilitate
more policy action. In particular, there is an economic efficiency-based case for public funding and promotion of
research on non-clinical preventive interventions, in Germany and beyond, to confront the peculiar challenges that
set this research apart from its clinical counterpart.
1. Background
Recent years have seen a growing research and policy
interest in primary prevention and health promotion in
many European countries and beyond. Some of the
interest has been fuelled by the expectation that preven-
tion may mitigate at least a share of the expected,
adverse fiscal consequences of demographic changes
[1-3]. The evidence to support this specific expectation
is at best mixed, however. Studies looking at various
countries with different data for different health condi-
tions find very inconsistent results about the cost-saving
potential of prevention or of improved health in general
[2,3]. Hence, while the hope for cost savings to be
reaped from prevention remains highly questionable,
there is no doubt that some preventive interventions
and policies, even in the area of chronic diseases, can be
a cost-effective investment bringing vital contributions
to society’s health and social welfare [4]. In this paper
we take a closer look at the situation of prevention pol-
icy in Germany, within the European context. We con-
fine the analysis to two areas of prevention that
arguably serve particularly well to illustrate the potential
for more and better prevention in Germany. We argue
in the following section that Germany is a particularly
interesting example in that the scope for prevention to
improve health is significant, while at the same time -
on the whole - efforts to engage more effectively in pre-
vention have not been forthcoming, despite the avail-
able, if not abundant evidence on highly cost-effective
preventive interventions. We apply the framework pub-
lished by Kingdon [5] in order to assess possible obsta-
cles for prevention policies in Germany. This framework
focuses more on the flow and timing of policy action
than on its component steps. Kingdon describes health
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stream” (Section 2.1), a “policy stream” (Section 2.2),
and a “politics stream” (Section 2.3). He argues that
only when these three streams are aligned and “flow”
together does a window of opportunity for policy change
open. However, if there are obstacles in any of these
streams, substantial change will be hampered. In closing
we point to the role and challenges of prevention
research (Section 2.4) in this context. We focus on the
risk factors of alcohol and tobacco, since these are well
established in the “problem stream”, and encouraging
health policy changes in this field have in fact been
implemented in some countries over the past years [6,7].
While this is a case study on Germany, a low priority
on prevention is arguably a rather common phenom-
enon in many if not all European countries (and
beyond). Hence, there is potential Europe-wide rele-
vance in the present article.
2. Discussion
2.1 The problem stream - the scope for prevention in
Germany
The rationale behind this stream is that a given situation
has to be a) identified as a problem and b) amenable to
human control, in order to have a chance at reaching
the policy agenda. An assessment of comparative indica-
tors, a chain of events, or other sources of feedback can
indicate such an issue and the need of the government
for some form of intervention.
Assessing the scope for health gains from more and/or
“better” prevention in any given country is a challenging
t a s k .H e r ew em a k eu s eo ft w o( i n e v i t a b l yi m p e r f e c t )
proxy indicators for the extent of “preventive efforts”
expended to date in Germany:
First, we review Germany’s record in terms of two risk
factors, alcohol use and smoking, that a) account for a
large share of the burden of disease and b) for which
there appears to be a widely shared consensus on the
set of evidence-based preventive interventions that
ought to be pursued [8,9]. Second, we look at Germany’s
implementation record of preventive policies or inter-
ventions. In both cases we use other European countries
as benchmarks.
Burden of preventable disease
Smoking In comparison with 14 other European coun-
tries, Germany shows, with 34% of its population above
15 years smoking on a daily basis, the second highest
rate of daily smokers [10]. The daily smoking rate of
31% for women is the highest in the EU-15. While other
data from the German national statistics office and
available only for Germany shows lower absolute rates
(due to differences in definitions and methods), these
data allow us to examine trends over the recent decade:
the percentage of smokers among respondents (aged
15-75) dropped from 28.3% in 1999 to 27.4% in 2003
and remained about the same in 2005 (27.2%), indicat-
ing only minor changes in smoking prevalence rates
[11]. While smoking rates among young people (aged
12-25) dropped from 35.5% in 2004 to 32% in 2008
[ 1 1 , 1 2 ] ,c u r r e n tr a t e sr e m a i na b o u ta sh i g ha si no t h e r
high-smoking countries in Europe, such as Austria and
the Eastern European countries [11,13].
Alcohol Germany ranks second among the EU-15 coun-
tries in terms of per capita alcohol consumption [10].
The average German consumes two litres more of pure
alcohol per year than the average EU-25 citizen [14]. In
particular the rise of excessive drinking patterns (espe-
cially binge drinking) among adolescents is alarming.
About 75% of Germany’s students aged 15-16 years con-
sumed alcohol during the 30 days prior to a survey held
in 2007, and 22% had been drunk during that period
[13]. These figures are again well above the European
(EU-25) average.
Prevention policies
Smoking The 2007 European Tobacco Control report
confirms a low degree of anti-tobacco policy implemen-
tation in Germany [15]. The very few existing vending
and advertising restrictions are largely based on volun-
tary agreements. Joossens and Raw [16] introduced the
Tobacco Control Scale in 2005 to capture the extent of
implementation of effective tobacco control policies, e.
g., pricing, bans in public places, advertising bans, health
warnings etc. [Figure 1]. In the latest ranking (2007),
Germany came 27th among 30 European countries,
trailed only by Greece, Luxembourg and Austria [7].
While some measures have been put in place to curb
youth smoking (e.g., setting the official smoking age to
18 years, requiring a bank card to buy cigarettes from
vending machines), overall efforts still appear half
hearted and of limited success [17]. As of 2007, more
than 80% of the adolescents reported access to tobacco
as “very or fairly easy” [13], probably not least because
of the comparative availability of vending machines: in
2008, there was one vending machine for about 205 citi-
zens in Germany. Vending machines account for 13.5%
of all tobacco sales in Germany [18]. About half the EU
countries have banned sales from vending machines
entirely [15].
Alcohol A report [14] comparing the policy efforts in
different European countries found that Germany
(alongside Romania) had the lowest effective, purchasing
power-adjusted tax rates on alcohol. At least partly due
to low tax rates, the purchasing prices for alcohol in
Germany are the lowest in the EU. In Germany alcohol
can be sold virtually anywhere without a special sales
licence. The minimum legal purchase age is 18 years for
spirits and 16 years for other alcoholic beverages. How-
ever, a substantial percentage of adolescents reported
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younger than the minimum age: 28.4% of under-16-
year-old students reported having bought beer, while
the numbers for wine or sparkling wine were 8.9%, for
so-called “alcopops” 16.0% and for spirits 12.1% [19].
Advertisements, in particular for spirits, have been sub-
ject to some, if voluntary, regulation. Major sport events
are often sponsored by manufacturers of alcoholic bev-
erages (e.g., the 2006 World Soccer Cup and the For-
mula One Championship). Beside Ireland, Italy, Poland,
the UK and Switzerland, Germany is one of the few
countries that do not allow randomised breath testing
(RBT) to identify and prevent drunk driving.
2.2 The policy stream - suitability of solutions for the
German context
The objective of this stream is to describe the suitability
of proposed solutions for a problem in terms of techni-
cal feasibility and acceptability within the population. In
light of tight budget constraints, one of the major
dimensions of feasibility nowadays is the efficiency (i.e.,
the value for money) of an intervention. The acceptabil-
ity of an intervention has to be analysed within the con-
text (i.e., social values, history) of the specific country in
question. Therefore, we first scrutinise the cost-effective-
ness of proposed solutions and then describe the
contextual factors which might be obstacles to health
policy change towards prevention.
The economic focus
Some might argue that part of the reason for the appar-
ently low efforts on prevention in Germany (and else-
where) might have to do with poor expected ‘value for
money’ to be had from any preventive interventions.
Such a view would, however, largely contradict current
evidence, which suggests that in particular in the above-
mentioned areas there are several highly cost-effective
measures that could be implemented, and have been
implemented in many other countries. In this section
we first briefly review the cost-effectiveness evidence for
interventions concerning the prevention of tobacco and
alcohol use and subsequently extend the discussion to
other areas, allowing us to also highlight the (no doubt
existing) limitations in the evidence.
Smoking There is substantial evidence on cost-effective-
ness of policies to prevent and reduce tobacco con-
sumption, even if much of this evidence comes from
outside Germany [20]. In particular tobacco taxation has
been identified as the most successful and cost-effective
measure in smoking reduction [21,22]. The same studies
also demonstrate the very favourable cost-effectiveness
of banning smoking at work and in public places. For
example a reduction of hospital admission for
The TCS measures the tobacco control activity in 30 European countries. The
scale is based on six policies which, according to the evidence, should be
prioritised in comprehensive tobacco control programmes, and where defined by
the WorldBank as follows:
- price increases through higher taxes on cigarettes and other tobacco  
products
- bans/restrictions on smoking in public and work places
- better consumer information, including public information campaigns, 
media coverage, and publicising research findings
- comprehensive bans on the advertising and promotion of all tobacco 
products, logos and brand names
- large, direct health warning labels on cigarette packs and other tobacco 
products
- treatment to help dependent smokers stop, including increased access to 
medications.
The allocation of weights according to importance of each policy (and therefore
the points allocated to each implemented policy) was determined by an
international expert panel. The maximum score is 100. The result for each country
is based on a questionnaire, completed by an expert in each country. Information
on legislation obtained from the correspondents via the questionnaire was
discussed and verified at the WHO tobacco legislation database.
(Adapted from Joossens and Raw, 2006)
Figure 1 The Tobacco Control Scale.
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legislation was shown [23]. Greater uncertainty sur-
rounds the (cost-)effectiveness of so-called “social mar-
keting” approaches, i.e., the idea of achieving social
health goals without repressive legislation, but rather by
influencing attitudes by publishing information and lob-
bying for “healthful” behaviour through different mar-
keting instruments [24]. Nevertheless, health warnings
on cigarette packs seem to have reduced consumption
by a detectable, yet small amount [21,22]. The analysis
of mass media campaigns has so far produced mixed
results. For instance, Abelson [25] claims that anti-
smoking advertising and education has no detectable
impact on aggregate consumption. However, anti-smok-
ing campaigns may affect consumption indirectly by
making tax increases and smoking ban policies more
acceptable. Other studies undertaken in the UK mention
more favourable results in terms of cost-effectiveness
and conclude that mass media intervention would cost
between £2,500 and £10,000 per Quality Adjusted Life
Year (QALY) gained. These findings echo those from
US-focused studies [26].
Alcohol Several international systematic reviews have
consistently shown alcohol taxation, drunk-driving
interventions (e.g., a combination of a low blood alco-
hol limit and random breath testing) as well as regula-
tions to reduce availability of alcohol through
minimum legal purchase age to be highly effective in
reducing alcohol-related harm. As a further example,
brief interventions for drinkers at risk have been
shown to be cost-effective [14,27]. In terms of cost-
effectiveness, estimates suggest that an excise tax
increase of about 50% is one of the most worthwhile
measures, which would cost about $287 per Disability
Adjusted Life Years (DALY) saved (excluding tax rev-
enue), followed by a comprehensive advertising ban,
which would cost $660 per DALY saved. Reduced
retail access and RBT can also be considered cost-
effective, at an estimated $1,208 and $2,741, respec-
tively, per DALY saved [21].
The above interventions only address a share, if a sub-
stantial one, of the total preventable disease burden in
Germany (and Europe), raising the question how much
we know about cost-effectiveness of prevention in other
areas. In recent years there has been a growing interest
in such research, as documented by a series of major
systematic reviews of the international literature [28-30].
While these studies do definitely document a significant
amount of encouraging economic evidence in favour of
primary prevention, they also acknowledge the limita-
tions of that literature. For instance, on the basis of
their systematic review of cost-effectiveness evidence for
primary prevention of cardiovascular diseases (CVD)
Schwappach and colleagues [30] found that
( 1 )O n l yv e r yf e ws t u d i e s assessed non-clinical
broader health promotion interventions targeted at
obesity, physical inactivity or dietary intake in chil-
dren or young adults.
(2) Interventions targeting children or young people
have only very rarely been evaluated in economic
terms, despite the high level of expected benefits
that are generally attributed to early prevention.
(3) The comparability of results between studies is
severely limited by the marked differences in the
methodologies and definitions applied.
From a German perspective, a further limitation is the
scarcity of country-specific studies. In the review of
Schwappach et al. mentioned above, a mere four studies
(out of 195) related to Germany [30]. Similarly, in a sys-
tematic review of all economic evaluations carried out
in the German health system context covering the per-
iod 1990-2004, only 36 out of 275 studies were found to
consider preventive measures (excluding screening). Of
those, only a small fraction was targeted at primary pre-
vention or population-based approaches [30,31]. Hence,
a rather strong case can be made for more research on
the subject in Germany (and elsewhere).
While evidence is at best one out of many determinants
of policy decisions, a more comprehensive evidence base
could facilitate decision-making, which at present often
follows more intuitive than scientific reasoning: the 2008
report of the compulsory health insurance funds [32]
(one of the financial and organisational key players for
prevention in the country) states that scientific evidence
has been used to implement a preventive measure by the
insurance funds in only 25% of the interventions
initiated. Moreover, only 33% of the projects that were
i m p l e m e n t e db yt h ei n s u r a n c ef u n d si nas e t t i n gc o n t e x t
used health parameters as evaluation criteria, and only
3% of the programmes have taken an economic perspec-
tive in their evaluation. By contrast, 71% of projects eval-
uated the satisfaction of the participants. Due to this lack
of outcome research in the German context, several
researchers try to translate evidence on preventive mea-
sures from other countries to the German healthcare sys-
tem context. During such a process of translation it is
important to consider structural conditions, which are
embedded in cultural dimensions and historical develop-
ments. Every culture has its own meaning of community,
patterns of decision-making, beliefs about health, help
seeking behaviour, notions of individualism versus collec-
tivism, attitudes toward the elderly, and approaches to
problem-solving [33]. These structural conditions define
a health system and affect an intervention’se f f e c t i v e n e s s ,
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these challenges in the translation process (e.g. through
appropriate modelling or pragmatic clinical trials), is part
of a persistent debate [34,35].
The focus of society
With seemingly few existing prevention efforts coupled
with at least significant evidence on what could be done
in the specific areas mentioned (and partly beyond), the
question arises of why one observes this contrast. In this
s e c t i o nw ee x p l o r eas e to fn o tm u t u a l l ye x c l u s i v e
hypotheses about obstacles to more and better (primary)
prevention in Germany.
A preference for “individualism”?
Part of the explanation for a limited public policy
response on prevention may be that the German popu-
lation simply does not demand such policies as it runs
against what some consider a very strong preference for
individual freedom and a dislike of government interfer-
ence in seemingly private business.
Interestingly, while such individual preferences are
hard to quantify, public opinion surveys tend not to
confirm a particularly individualistic preference among
the German population. The World Value Survey asks
respondents in many countries whether “people should
take more responsibility to provide for themselves”,o r
“the government should take more responsibility to
ensure that everyone is provided for”. Overall, Germany
ranks among the European countries with the highest
preference for government involvement [36]. There is,
however, a clear distinction between Eastern and Wes-
tern Germany in that the latter displays a significantly
more individualistic attitude than the former, possibly
due to different historical experiences [37].
In the debate on government’s role in prevention, the
overarching principle of individual freedom has fre-
quently been invoked as a counter-argument to an aug-
mented public policy stance on prevention, especially in
relation to policies that would seek to change people’s
health-related behaviour. If the above opinion survey
results are an accurate representation of the German
population’s preferences on government intervention in
the health behaviour arena, then such counter-argu-
ments would appear unfounded.
The introduction of non-smoking regulations in Ger-
many (referred to in more detail below) may further
illustrate this debate. Opponents to the regulations warn
against what they see as an overly paternalistic approach
that is at odds with other “free market” values [38].
However, several recent opinion polls have shown that
legal regulations to ban smoking in public restaurants
meets the approval of about three quarters of the popu-
lation [39].
Hence, the individualism hypothesis is not really
backed up by what the population as a whole feels, as
opposed to a group of stakeholders and opinion leaders
opposed to more intrusive prevention policies.
The question remains, however, how to better align
individual preferences and public health goals in general.
Research identified the concept of personal risk percep-
tion as an important factor for individual behaviour as
well as for attitudes towards government intervention
[40,41]. A lack of coherence between individual prefer-
ences and public health measures might arise, if indivi-
duals perceive restrictions in their personal freedom and
choice as being disproportionate to the perceived risk of
harm to the general public [41-43]. Two major findings
are that first, people tend to evaluate risks of unwanted
effects as higher for “others” than when applied to
themselves, and second, people tend to be “myopic”
towards risks that are delayed far into the future
[41,44,45]. A possible pathway for public health policy
might therefore be to strengthen messages of more
short-term adverse events and externalities of behaviour,
next to suitable solutions, in order to align the indivi-
dual risk perception with community health goals. An
example, referring to the case above, is the change in
focus within the “smoking in public places” debate from
the harm smoking does to the smoker herself to the
harm inflicted upon third persons ("external costs”)
through passive smoking, which may have added
momentum to smoking-related public health advocacy
[46]. This idea could be transferred to the area of alco-
hol by articulating the effects of alcohol consumption
on road traffic accidents and anti-social behaviour, as
opposed to stressing “private” long-term outcomes such
as liver cirrhosis. A further discussion of this mechanism
and the role of public (health) policies in this task is
beyond the scope of this article. However, more research
in this area is needed.
History
Another potential obstacle to more prevention and
health promotion arguably consists in their negative
connotation with aspects of public health activities dur-
ing the Third Reich era (1933-45), often defined by the
term “Volksgesundheit” [47,48]. During this period the
principle of “only a healthy nation is a strong nation”
was taken as justification for, among others, interven-
tions to enforce physical activity and to combat alcohol
and tobacco use. The idea also incorporated the per-
verted ideas of racial hygiene and eugenics - including
the notorious activities concerning “euthanasia” and
mass sterilization of people with handicaps or deemed
“unfit” [49]. This extremely negative historical legacy of
prevention and public health may explain a degree of
over-sensitivity even nowadays. Justified or not, the con-
cern that public health (i.e., the health of the population
as whole) might become more important than the indi-
vidual’s freedom and personal “pursuit of happiness” is
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in Germany [50].
2.3 The politics stream - the German health political
system: lack of incentives and dispersed power as
obstacles for prevention
The politics stream describes the political context in
which health policy is set. Since policy change is depen-
dent on actors working together and reaching compro-
mises, the attitudes and interests of each institution or
individual involved needs to be aligned (e.g., through
bargaining) in order to facilitate change. While some
authors commonly use this section to describe changes
in political actors over time (e.g., change in govern-
ment), we apply this part of the framework to analyse
the underlying structure of the German political system
that is concerned with health policy. We try to identify
whether structural problems in the organisation of legis-
lation, the nature of social health insurance, or the influ-
ence of actors from private industry represent obstacles
to the formulation and implementation of prevention
policies.
The federal system and its actors
Germany’s public policy in many areas, including health-
care, follows a federal (meaning shared sovereignty)
rather than a centralised decision-making process. In par-
ticular, each state has the right to implement (or reject)
laws on prevention. Taken together, there is a multitude
of players, at national and state level, all contributing par-
tially to prevention in Germany. The much-dispersed
responsibilities and interests may well hinder the imple-
mentation of prevention policies that would otherwise
benefit from coordination and harmonisation across
regional borders. The recent debate around smoking ban
laws is a case in point. In 2007 a national law was enacted
banning smoking in public facilities, but the legislation
that concerns smoking bans in restaurant and bars was
transferred to the state level and resulted in a range of
very diverse regulations, some of them complex, based
on voluntary efforts with multiple exceptions for small
bars, clubs and places holding traditional events [51].
Some innkeepers filed a lawsuit against the states’ smok-
ing prohibition at the Federal Constitutional Board. The
court decided that such a law was in accordance with the
German constitution because the government has the
duty to safeguard the life and health of the general popu-
lation. However, it has to be guaranteed that the federal
legislation ensures both equality and consistency for all
parties involved [52].
In response to the built-in exceptions, such as the free-
dom to run so-called “smoking clubs” to which only
registered members have access, a petition for a referen-
dum was initiated in the state of Bavaria (enrolment per-
iod November 19
th - December 2
nd). The aim of the
petition is a unified law for the protection of non-smo-
kers without exceptions. The petition has exceeded the
necessary proportion of 10% of eligible voters, so a refer-
endum was scheduled for July 4
th 2010 and approved by
61% of the population (voter participation 38%).
An additional, related problem may be that there is no
central agency for public health in Germany that could
help coordinate prevention policies where suitable. This
leads to uncoordinated prevention measures on all fed-
eral levels (national, state, community), which tend to
lack evaluation and/or evidence for effectiveness. In con-
trast, often programmes are continued, even though
proved to be unsuccessful (e.g., certain behaviour-based
approaches to prevent smoking in schools) [53].
In Germany, the Federal Centre for Health Education
(BZgA) is a central institution for health promotion and
preventive activities. Nevertheless, not all health topics
are covered broadly. The BZgA focuses especially on
national campaigns on tobacco and alcohol, as well as
HIV prevention.
Another coordination problem arises through the
compulsory health insurance funds, which are at least in
principle expected to play a major role in prevention
[ F i g u r e2 ] .T h e r ea r ea p p r o x imately 200 funds of this
kind in Germany, mostly organized at the state level.
They have gained more legal rights recently to offer pre-
ventive measures to their customers. In 2008, insurance
funds spent the highest amount ever for primary pre-
vention: almost €340 million, which is equal to €4.83
per insurant, i.e., well above the requested amount of
€2.74 for prevention per person and year. Substance
abuse is not an explicit target of this programme, but is
considered as one (minor) point within the scope of
workplace health promotion and primary prevention
activities within the “setting approach”, e.g., measures in
schools to improve life-skills [32]. The insurance funds
are also allowed to incentivise their members through
programmes such as monetary compensation or free fit-
ness centre memberships. Critically though, they can
only finance these incentives from cost savings. This is
u n l i k e l yt ob eas e n s i b l ee c o n o m i cr e q u i r e m e n t ,a sp r o -
grammes that would still provide good value (i.e., health
gains) for money would have to be forgone, just because
they do not meet the overly stringent criteria of cost-
saving. Given that customers are free to switch to
another insurance fund, these programmes are rather
used as marketing tools than as concerted prevention
efforts.
Particularly powerful industrial lobby
The overall lack of coordination and responsibility tends
to produce a vacuum of interpretation sovereignty on
prevention topics. This might be one reason why in
Germany industrial lobbyists have a strong influence on
legislation and fiscal measures, arguably particularly so
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tion of the smoking ban in public places may exemplify
the influence of the tobacco lobby [54], as may the
industry’s strategies to oppose the advertisement ban at
the European level as well as managing to maintain the
establishment of different tax levels for different types of
tobacco [39,55]. By contrast, some other preventive
measures, e.g., vaccination for HPV, were introduced to
the catalogue of publicly financed interventions at a sur-
prisingly early stage (even before the major effectiveness
studies were published), despite the explicit concerns
by several research groups [56]. The decision process
was accompanied by a large industry-funded media
campaign.
2.4 The role of research
The case for greater public support for research on pre-
vention, especially of the non-clinical sort, has already
been highlighted above. Research on preventive inter-
ventions is subject to a market failure: the private actors
do not have the incentive to engage in such research,
because (a large share of) the resulting insights would
become a public good that everybody could use, without
having paid the often substantial research costs to arrive
at that knowledge. From a sheer economic efficiency
(and not even from any moral or public health) perspec-
tive, such knowledge is thus undersupplied compared to
the social optimum. Hence, government ought to step
in and help promote the production of evidence that the
population at large would benefit from, but cannot pro-
duce if decisions are left to “the market” alone [57].
The development of a sound scientific basis and struc-
tured financial support can improve the impact of
healthcare, as appears to have been the case in the Ger-
man rehabilitation services sector. The establishment of
a long-term research programme has improved the
recognition and outcomes of rehabilitation services - a
traditionally rather neglected area.
Prevention research, especially in the non-clinical
arena, poses its own challenges, arguably the chief one
being the attribution of changes in health outcomes to
the intervention examined [58]. Population-based inter-
ventions tend to be more complex than the prescription
and intake of a drug, and the (not flawless) gold stan-
dard of evaluation in the medical field - the randomised
controlled trial (RCT) - cannot easily be implemented.
Fortunately, though, there are other statistical methods
that may allow the assessment of causality in such cases,
but they have been underutilized in public health
research to date [59,60].
A low public support for non-clinical research is of
course not solely a feature of Germany but may well
apply globally. This is exemplified by one of the rare
attempts to quantify the extent of funding for health
research in the UK recently, showing that prevention
research accounts for only 2% of the overall research
funding on health (with only a small fraction of this
related more specifically to primary prevention or health
promotion) [61]. While similar data do not exist for
Germany, there is no reason to assume that the share is
significantly higher in Germany. Nevertheless, there are
also some positive trends: in 2003 the German Ministry
of Education and Research made available more than
€ 20 million for research projects on primary prevention
and health promotion. This programme is running from
2004 until 2012 and includes 60 research projects
[http://www.knp-forschung.de/]. The Federal Centre for
Health Education (BZgA) is a partner in this national
comprehensive network to strengthen research in pri-
mary prevention, with the objective of establishing
In Germany, health care funding for about 90% of the population is organised
through statutory health insurance funds, which act at “arm’s length” from the
government. Around 200 funds collect “premiums” through earmarked payroll
taxes. These (non-progressive) taxes are paid in equal parts by the employer and
employee to the social health insurance fund.
There is a mechanism, called risk adjustment, for redistributing resources among
funds according to the risk structure of their clients. Employees are free to choose
their preferred social health insurance fund. However, the premium remains the
same, independent of the insurance fund they are enrolled in. Therefore, insurance
funds rather compete on (perceived) quality and responsiveness and not on price.
The idea of the system goes back to the Social Reforms in the Bismarckian era in
the 19th century. It is often referred to as a “sickness fund” system, since its
primary focus is on paying for health services (which are mostly delivered by
private actors) in cases of ill health. Prevention as an additional focus was
introducedonly in recent years.
Figure 2 A brief overview of the German Statutory Health Insurance system.
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Page 7 of 9structures for sustainable primary prevention. Tasks
include process definitions, evaluation of combined
results and communication to political decision makers,
research community and practical institutions. In the
intermediation between science and the practical field,
the BZgA could play an even greater role.
3. Summary
In Germany, substantial health gains could be reaped
from the implementation of evidence-based, cost-
effective preventive interventions and policies. How-
ever, applying the “three-streams” framework proposed
by Kingdon [5], we showed that there are obstacles in
the policy and politics streams that hinder substantial
policy change. Barriers to more prevention include
social, historical, political, legal and economic factors.
While in the “problem stream” there is sufficient evi-
d e n c et os c a l eu pp r e v e n t i o ne f f o r t si ns o m ep u b l i c
health areas in Germany, especially alcohol and
tobacco, in general there is a comparative shortage of
research on non-clinical preventive interventions.
Some of the existing barriers in Germany are at least
in principle amenable to change, provided the political
will is sufficient. However, political decisions tend to
be driven by short term election period perspectives,
and hence the long term horizons of many prevention
policies may not always align with political decision-
makers’ time horizons. More research on prevention
by itself is no panacea but could help facilitate more
policy action. In particular, there is an economic effi-
ciency-based case for public funding and promotion of
research on non-clinical preventive interventions [57],
in Germany and beyond, to confront the peculiar chal-
lenges that set this research apart from its clinical
counterpart.
I ti sb e y o n dt h es c o p eo ft h ep r e s e n ta r t i c l et o
exhaustively discuss all the options for a more con-
certed effort on prevention in Germany. We highlighted
only selected key points where improvement seems
necessary and feasible. This does not readily provide us
w i t hac o m p l e t ep o s i t i v em o d e lo fh o wp r e v e n t i o na sa
whole ought to be institutionalised in Germany or any
other country. With wide variation in how prevention is
delivered and institutionalised across European coun-
tries [62], a single optimal model has yet to emerge.
While lack of the perfect model is no excuse for inac-
tion on prevention in Germany, completing the picture
of the features of such an ideal model of a national pre-
vention policy should be high on the public health and
social science research agenda. For this purpose interna-
tional cross-country comparative research, rather than a
single country case study would seem one promising
approach.
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